FDA appropriations bill passes House
This article was originally published in The Tan Sheet
Executive Summary
The House on Aug. 2 passed its appropriations bill, H.R. 3161, that includes FDA funding, which proposes $1.69 bil. in direct funding for the agency. No significant changes affecting FDA were made from the bill sent top the floor by the Agriculture Appropriations Subcommittee (1"The Tan Sheet" July 23, 2007, p. 4). The same day, Sen. Mike Enzi, R-Wyo., asked Majority Leader Harry Reid, D-Nev., to delay naming conferees for the legislation. "If we do this too early, we set ourselves up for the blame game, not for getting this key legislation done," Enzi said. The Senate has not yet passed its corresponding bill, S. 1859...
You may also be interested in...
Appropriators Boost FDA Budget For Food Safety While Opposing Lab Closings
House and Senate appropriators make it known in reports on FDA's fiscal 2008 appropriation that they question the agency's plan to close more than half of its field labs, with the House bill specifically banning funding for the reorganization
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: